Mason Street Advisors’s Novo Nordisk NVO Stock Holding History

Mason Street Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-466,470	Closed	-$9.87M	–	1665
2014 Q4	$9.87M	Hold	466,470	–	–	0.07%	338
2014 Q3	$11.1M	Hold	466,470	–	–	0.09%	275
2014 Q2	$10.8M	Hold	466,470	–	–	0.08%	293
2014 Q1	$10.6M	Hold	466,470	–	–	0.09%	284
2013 Q4	$8.62M	Hold	466,470	–	–	0.07%	336
2013 Q3	$7.89M	Buy	+466,470	New	+$7.85M	0.09%	259

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mason Street Advisors's NVO Position: Q1 2015 in Review

Mason Street Advisors sold out of Novo Nordisk (NVO) in Q1 2015, closing a stake of 466,470 shares — an estimated $9.87M sold.

Mason Street Advisors first reported a position in NVO in Q3 2013 and held it in 6 quarters. The position peaked at $11.1M in Q3 2014. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

Mason Street Advisors reported no remaining Novo Nordisk position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 466,470 Novo Nordisk shares in Q1 2015, an estimated $9.87M.
Mason Street Advisors first reported a position in Novo Nordisk in Q3 2013 and held it in 6 quarters.
Mason Street Advisors's Novo Nordisk position peaked at $11.1M in Q3 2014.
505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.